Recordati Industria Chimica e Farmaceutica SPA (RER1) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RER1 Analyst Ratings

Hold

0 Buy

1 Hold

0 Sell

Based on 1 analysts giving stock ratings to

Recordati

Industria Chimica e Farmaceutica SPA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RER1 Stock 12 Month Forecast

Average Price Target

€50.00

▲(0.08% Upside)

Based on 1 Wall Street analysts offering 12 month price targets for Recordati Industria Chimica e Farmaceutica SPA in the last 3 months. The average price target is €50.00 with a high forecast of €50.00 and a low forecast of €50.00. The average price target represents a 0.08% change from the last price of €49.96.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"45":"€45","47":"€47","49":"€49","51":"€51","53":"€53"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€50.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[45,47,49,51,53],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.25,51.15384615384615,51.05769230769231,50.96153846153846,50.86538461538461,50.76923076923077,50.67307692307692,50.57692307692308,50.48076923076923,50.38461538461539,50.28846153846154,50.19230769230769,50.09615384615385,{"y":50,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.25,51.15384615384615,51.05769230769231,50.96153846153846,50.86538461538461,50.76923076923077,50.67307692307692,50.57692307692308,50.48076923076923,50.38461538461539,50.28846153846154,50.19230769230769,50.09615384615385,{"y":50,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.25,51.15384615384615,51.05769230769231,50.96153846153846,50.86538461538461,50.76923076923077,50.67307692307692,50.57692307692308,50.48076923076923,50.38461538461539,50.28846153846154,50.19230769230769,50.09615384615385,{"y":50,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.058,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":48.942,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.62,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":50.89,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":50.208,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":49.271,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":47.555,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":46.648,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.313,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.443,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.542,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.25,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€50.00

Average Price Target€50.00

Lowest Price Target€50.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Charles Pitman CFA

Barclays

€50

Hold

0.08%

Upside

Reiterated

07/30/26

Barclays Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Niccolo Guido Storer

Kepler Capital

€57.5

Buy

15.09%

Upside

Reiterated

04/21/26

Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€56

Buy

12.09%

Upside

Initiated

03/03/26

Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas

James Gordon

J.P. Morgan

€67→€70

Buy

40.11%

Upside

Reiterated

12/08/25

Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan

Alistair Campbell

RBC Capital

€56

Hold

12.09%

Upside

Reiterated

08/11/25

RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

James Vane

Jefferies

€61.5

Buy

23.10%

Upside

Upgraded

08/11/25

Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Charles Pitman CFA

Barclays

€50

Hold

0.08%

Upside

Reiterated

07/30/26

Barclays Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Niccolo Guido Storer

Kepler Capital

€57.5

Buy

15.09%

Upside

Reiterated

04/21/26

Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

€56

Buy

12.09%

Upside

Initiated

03/03/26

Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas

James Gordon

J.P. Morgan

€67→€70

Buy

40.11%

Upside

Reiterated

12/08/25

Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan

Alistair Campbell

RBC Capital

€56

Hold

12.09%

Upside

Reiterated

08/11/25

RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

James Vane

Jefferies

€61.5

Buy

23.10%

Upside

Upgraded

08/11/25

Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed

Stocks with the Highest Top Analyst Consensus in the General Sector

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

CBRSCerebras Systems, Inc. Class A

FRVOFervo Energy Company Class A

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Recordati Industria Chimica e Farmaceutica SPA

3 Months

Niccolo Guido StorerKepler Capital

Success Rate

3/3 ratings generated profit

Average Return

+5.03%

Copying Niccolo Guido Storer's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.03% per trade.

1 Year

Niccolo Guido StorerKepler Capital

Success Rate

3/3 ratings generated profit

Average Return

+6.93%

Copying Niccolo Guido Storer's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.

2 Years

Niccolo Guido StorerKepler Capital

Success Rate

3/3 ratings generated profit

Average Return

+6.93%

Copying Niccolo Guido Storer's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RER1 Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RER1 has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. RER1 average Analyst price target in the past 3 months is 50.00.

Each month's total comprises the sum of three months' worth of ratings.

RER1 Financial Forecast

RER1 Earnings Forecast

The previous quarter’s earnings for RER1 were €1.29.

RER1 Sales Forecast

Next quarter’s sales forecast for RER1 is €674.80M with a range of €674.80M to €674.80M. The previous quarter’s sales results were €697.36M. RER1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.21% of the time in the same period. In the last calendar year RER1 has Performed in-line its overall industry.

RER1 Stock Forecast FAQ

What is DE:RER1’s average 12-month price target, according to analysts?

Based on analyst ratings, Recordati Industria Chimica e Farmaceutica SPA’s 12-month average price target is 50.00.

What is DE:RER1’s upside potential, based on the analysts’ average price target?

Recordati Industria Chimica e Farmaceutica SPA has 0.08% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Recordati Industria Chimica e Farmaceutica SPA a Buy, Sell or Hold?

Recordati Industria Chimica e Farmaceutica SPA has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Recordati Industria Chimica e Farmaceutica SPA’s share price target?

The average share price target for Recordati Industria Chimica e Farmaceutica SPA is 50.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €50.00 ,and the lowest forecast is €50.00. The average share price target represents 0.08% Increase from the current price of €49.96.

What do analysts say about Recordati Industria Chimica e Farmaceutica SPA?

Recordati Industria Chimica e Farmaceutica SPA’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Recordati Industria Chimica e Farmaceutica SPA?

To buy shares of DE:RER1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Recordati Industria Chimica e Farmaceutica SPA (RER1) Stock Forecast & Price Target

RER1 Analyst Ratings

RER1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Recordati Industria Chimica e Farmaceutica SPA

RER1 Analyst Recommendation Trends

RER1 Financial Forecast

RER1 Earnings Forecast

RER1 Sales Forecast

RER1 Stock Forecast FAQ

Detailed List of Analyst Forecasts